HISAMITSU PHARMACEUTICAL CO. INC. financial statements, including revenue, expenses, profit, and loss
The total revenue of 4530 for the last quarter is 38.88 B JPY, and it's 8.45% higher compared to the previous quarter. The net income of Q4 23 is 1.86 B JPY.